Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

GR-SAFS: A Graph-Regularized Stacking Framework with Adaptive Feature Selection for High-Dimensional Prognostic Biomarker Discovery

Created on 30 Jun 2026

Authors

He, J., Guan, J.

Abstract

Identifying prognostic biomarkers from high-dimensional transcriptomic data poses a triple challenge: achieving sparsity, preserving biological network topology, and integrating complementary nonlinear signals. Existing methods typically ignore network structure, miss nonlinear interactions, or lack a principled mechanism to fuse heterogeneous model outputs. We introduce GR-SAFS (Graph-Regularized Stacking with Adaptive Feature Selection), a framework with three modules: a Graph-Lasso engine embedding gene co-expression network Laplacian priors, run in parallel with a Random Forest engine; an empirical cumulative distribution function (eCDF) alignment layer that places sparse and dense importances on a common percentile scale; and a diversity-penalized quadratic programming router whose strict convexity yields a unique global optimum. On the TCGA-LUAD cohort, GR-SAFS identifies a 20-gene signature with a training concordance index of 0.700. Across two independent crossplatform microarray cohorts, GR-SAFS is the only method whose frozen signature retains statistically significant risk stratification in every cohort, where stronger-C-index baselines lose significance on at least one external cohort. Functional enrichment anchors the signature to a coherent Wnt/{beta};-catenin axis. An open-source implementation is released for full reproducibility.

Preprint server: bioRxiv
The authors list and abstract were imported from bioRxiv on 30 Jun 2026.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this preprint? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 9
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement